Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$BGS $BCC $CBAY $LYRA $MGNX $PDD $TWLO

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Wednesday, 27 May, as follows:

B&G Foods Inc. (NYSE:BGS): this green giant is hot. Shares most recently closed at 22.82 and has a consensus price target of 17.43.

Boise Cascade Co. (NYSE:BCC) was raised to Buy from Neutral with a 39 price target at BofA Securities.

CymaBay Therapeutics Inc. (NASDAQ:CBAY) was raised to Buy from Neutral with a 9 price target at H.C. Wainwright.

Lyra Therapeutics Inc. (NASDAQ:LYRA) was started with a Buy rating and a 24 price target at Jefferies.

Macrogenics Inc. (NASDAQ:MGNX) was reiterated as Buy and its price target was raised to 40 from 22 at HC Wainwright.

Pinduoduo Inc. (NASDAQ:PDD) was reiterated as Buy and its target was raised to 76 from 38 at Benchmark. The the consensus price target was at 43.31.

Twilio Inc. (NYSE:TWLO) was reiterated as Buy and its price target was raised to 225 from 170 at Needham.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   

Latest posts by Paul Ebeling (see all)